Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and Spain.

Saved in:
Bibliographic Details
Title: Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and Spain.
Authors: Briody J; Data Science Centre, School of Population Health, RCSI University of Medicine and Health Sciences, Beaux Lane House, Lower Mercer St, Dublin 2, Ireland. jonathanbriody@rcsi.ie., Miller IS; Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, Ireland., O'Mahony JF; School of Economics, University College Dublin, Dublin, Ireland.; Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands., Tilson L; St James Hospital, National Centre for Pharmacoeconomics, Dublin, Ireland., O'Farrell AC; Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, Ireland., Chen Q; The Pennsylvania State University Libraries, Penn State Abington, Abington, PA, USA., Murphy V; Cancer Trials Ireland, Dublin, Ireland., Casey O; Cancer Trials Ireland, Dublin, Ireland., Schulte N; Department of Medicine II, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany., Ebert MP; Department of Medicine II, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany., Prehn JHM; Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, Ireland., Lambrechts D; Department of Human Genetics, Laboratory for Translational Genetics, VIB Center for Cancer Biology, Katholieke Universiteit Leuven, 3000, Leuven, Belgium., Ylstra B; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Dienstmann R; Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; University of Vic-Central University of Catalonia, Vic, Spain., Byrne AT; Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, Ireland., Bennett K; Data Science Centre, School of Population Health, RCSI University of Medicine and Health Sciences, Beaux Lane House, Lower Mercer St, Dublin 2, Ireland.
Source: PharmacoEconomics [Pharmacoeconomics] 2026 Mar; Vol. 44 (3), pp. 359-374. Date of Electronic Publication: 2026 Feb 04.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-2027
DOI:10.1007/s40273-025-01585-x